[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile

CAS: 252917-06-9

Ref. AN-AG00385A

Product Information

• Name: [2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile
• Synonyms: [u'Chir 99021', u'Chir-99021', u'Chir99021', u'CT 99021', u'CT-99021', u'CT99021', u'CHIR-99021', u'252917-06-9', u'CHIR99021', u'CHIR 99021', u'CT99021', u'CT 99021', u'CT-99021', u'GSK-3 Inhibitor XVI', u'UNII-234CMT4GK4', u'CHIR-911', u'CHIR-99021 (CT99021)', u'6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile', u'234CMT4GK4', u'CHEMBL412142', u'6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile', u'6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile', u'AK311166', u'6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile', u'C22H18Cl2N8', u'3-Pyridinecarbonitrile, 6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl)amino)ethyl)amino)-', u'3-PYRIDINECARBONITRILE, 6-[[2-[[4-(2,4-DICHLOROPHENYL)-5-(5-METHYL-1H-IMIDAZOL-2-YL)-2-PYRIMIDINYL]AMINO]ETHYL]AMINO]-', u'6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile', u'6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile', u'CHIR 911', u'AQGNHMOJWBZFQQ-UHFFFAOYSA-N', u'6-[(2-([4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile', u'6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino)ethyl)amino]pyridine-3-carbonitrile', u'6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile', u'65C', u'Kinome_3785', u'cc-59', u'SCHEMBL151139', u'BIFK0014', u'GTPL8014', u'CHEBI:91091', u'CTK4F5391', u'KS-00000XOW', u'AOB3866', u'DTXSID90179931', u'EX-A535', u'QCR-164', u'SYN5163', u'ZX-AFC000324', u'BCPP000285', u'BCP01901', u'2318AH', u'ABP000490', u'BDBM50325983', u'MFCD11846251', u's1263', u'ZINC29053046', u'AKOS015904410', u'AKOS026750421', u'AM81240', u'AN-1244', u'BCP9000520', u'CS-0181', u'KIN0002408', u'RL02837', u'SB19266', u'CHIR-99021,CT99021', u'NCGC00250379-01', u'NCGC00250379-03', u'NCGC00250379-09', u'AC-25532', u'AS-16523', u'HY-10182', u'SC-62210', u'CHIR99021, >=98% (HPLC)', u'FT-0700271', u'A25048', u'S-7733', u'CHIR99021(CT99021)/CT-99021', u'J-015915', u'J-518185', u'BRD-K16189898-001-02-9', u'BRD-K16189898-001-04-5', u'BRD-K16189898-001-09-4', u'BRD-K16189898-001-10-2', u'BRD-K16189898-001-11-0', u'BRD-K16189898-001-15-1', u'I14-17021', u'6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidaz', u'CT99021, 252917-06-9', u'3-Pyridinecarbonitrile,6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-', u'6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile', u'6-[(2-{[4-(2,4-dichlorophenyl) -5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile'], 3-Pyridinecarbonitrile, 6-[[2-[[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-, 3-Pyridinecarbonitrile, 6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-, 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile, Chir 911, Chir 99201, Chir-99021, Chir99021, Cihr 99021, Ct 99021, GSK 3 inhibitor XVI, Gsk 3Ixv, Laduviglusib
• CAS: 252917-06-9
• Brand: Indagoo

Chemical properties

• Molecular weight: 465.3379
• Formula: C₂₂H₁₈Cl₂N₈
• Purity: 98%
• Color/Form: Solid
• InChI: InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)
• InChI key: AQGNHMOJWBZFQQ-UHFFFAOYSA-N